Lyell Immunopharma, Inc. (LYEL)
NASDAQ·Healthcare·Biotechnology
$15.70
+5.62%
Mkt Cap $279.31M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$42.67
Range $34.00 – $49.00
Implied Upside
+171.9%
Consensus $42.67 vs current $15.70
NASDAQ·Healthcare·Biotechnology
$15.70
+5.62%
Mkt Cap $279.31M
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$42.67
Range $34.00 – $49.00
+171.9%
Consensus $42.67 vs current $15.70